Niagen Bioscience (NAGE) Long-Term Deferred Tax (2016 - 2019)

Niagen Bioscience (NAGE) has 4 years of Long-Term Deferred Tax data on file, last reported at $218000.0 in Q4 2019.

• On a quarterly basis, Long-Term Deferred Tax fell 99.01% year-over-year to $218000.0 in Q4 2019; TTM through Dec 2019 was $218000.0, a 99.01% decrease from a year earlier, with the FY2019 full-year figure at $218000.0, down 99.01% from the prior year.
• Long-Term Deferred Tax for Q4 2019 stood at $218000.0, down from $22.1 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for NAGE reached as high as $22.1 million in Q4 2018 and fell as low as $144000.0 in Q4 2017.
• Historically, Long-Term Deferred Tax has averaged $4.6 million across 4 years, with a median of $399000.0 in 2016.
• Across the five-year window, Long-Term Deferred Tax surged 15225.69% in 2018 and tumbled 99.01% in 2019, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $399000.0 in 2016, then sank by 63.91% to $144000.0 in 2017, then jumped by 15225.69% to $22.1 million in 2018, then tumbled by 99.01% to $218000.0 in 2019.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $218000.0 in Q4 2019, $22.1 million in Q4 2018, and $144000.0 in Q4 2017.